| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |